Forte Biosciences (FBRX) EBITDA (2016 - 2025)
Forte Biosciences (FBRX) EBITDA from Mar 31, 2016 to Dec 31, 2025. The TTM Forte Biosciences (FBRX) EBITDA is -$71M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Forte Biosciences (FBRX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +93.13% |
| 3 Years TTM | +71.97% |
| 5 Years TTM | +8.84% |
| All Time TTM | +9.30% |
Annual EBITDA change of Forte Biosciences (FBRX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$71M | +93.08% |
| 2024 | -$37M | +12.56% |
| 2023 | -$32M | +134.01% |
| 2022 | -$14M | -35.29% |
| 2021 | -$21M | -53.60% |
| 2020 | -$46M | +1041.48% |
| 2019 | -$4.05M | +965.79% |
| 2018 | -$380K | -98.98% |
| 2017 | -$37M | +18.80% |
| 2016 | -$31M | +38.34% |
| 2015 | -$23M | N/A |
Comparison Forte Biosciences (FBRX) five years EBITDA CAGR with competitors
Forte Biosciences (FBRX) five years EBITDA CAGR is 8.84%.